The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study.

Christina V OlesonRalph J MarinoChristopher S FormalChristopher M ModleskyBenjamin E Leiby

Published in: Spinal cord (2020)

ZA administered ≤21 days of complete traumatic SCI maintains aBMD at the hip and distal femur at 4 months post injury. This effect is partially maintained at 12 months.

Keyphrases

spinal cord injury
bone loss
spinal cord
neuropathic pain
liver failure
respiratory failure
minimally invasive
bone mineral density
total hip arthroplasty
hepatitis b virus